RT Book, Section
A1 Vaughn, David J.
A2 Loscalzo, Joseph
A2 Fauci, Anthony
A2 Kasper, Dennis
A2 Hauser, Stephen
A2 Longo, Dan
A2 Jameson, J. Larry
SR Print(0)
ID 1190481243
T1 Testicular Cancer
T2 Harrison's Principles of Internal Medicine, 21e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264268504
LK accessmedicine.mhmedical.com/content.aspx?aid=1190481243
RD 2024/04/19
AB Testicular  germ  cell  tumors  (GCTs)  represent  95%  of  all  testicular  neoplasms.  Non-GCTs  of  the  testis  are  much  less  common.  Approximately  5%  of  GCTs  arise  in  extragonadal  locations  including  the  mediastinum,  retroperitoneum,  and  pineal  gland.  Treatment  for  testicular  GCTs  is  determined  by  pathology  and  stage.  The  development  of  effective  chemotherapy  for  this  disease  represents  a  landmark  achievement  in  oncology.  About  95%  of  newly  diagnosed  patients  with  testicular  GCTs  will  be  cured.  For  this  reason,  testicular  cancer  has  been  called  “a  model  for  a  curable  neoplasm.”